Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy

2001217 citationsJournal Articlebronze Open Access

Authors

Nigishi Hotta · Nagoya University

Takayoshi Toyota · Tohoku University

Kempei Matsuoka · Saiseikai Central Hospital

Yukio Shigeta · Shiga University of Medical Science

Ryuichi Kikkawa · Shiga University of Medical Science

Toshio Kaneko · Japan Organization of Occupational Health and Safety

Akira Takahashi

Abstract

The effects of fidarestat-treatment on nerve conduction and the subjective symptoms of diabetic neuropathy provide evidence that this treatment alters the progression of diabetic neuropathy.

Topics & Keywords

Aldose Reductase and Taurine Pain Mechanisms and Treatments Pharmacology and Obesity Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 24, Issue 10, pp. 1776-1782

DOI: 10.2337/diacare.24.10.1776

Field-Weighted Citation Impact: 4.71